Kathryn L. Biberstein
Director/Board Member at Meridian Stories
Profile
Kathryn L.
Biberstein is currently the Director at Meridian Stories and Director at Triplet Therapeutics, Inc. She previously worked as the Executive VP, Chief Compliance & Legal Officer at Alkermes, Inc. and as the General Counsel at Serono SA. She also worked as Counsel at Crowell & Moring LLP and as Member-Executive Board at The World Economic Forum USA, Inc. She was the Secretary & Chief Compliance Officer at Alkermes Plc from 2017 to 2018.
Ms. Biberstein received her undergraduate degree from Kettering University and her graduate degree from The University of Michigan Law School.
Kathryn L. Biberstein active positions
| Companies | Position | Start |
|---|---|---|
| Meridian Stories | Director/Board Member | - |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | Director/Board Member | 2020-11-16 |
Former positions of Kathryn L. Biberstein
| Companies | Position | End |
|---|---|---|
| ALKERMES PLC | Chief Administrative Officer | 2018-02-28 |
Crowell & Moring LLP
 Crowell & Moring LLP Miscellaneous Commercial ServicesCommercial Services Crowell & Moring LLP provides legal services. It offers litigation and arbitration, regulatory, and transactional matters. The firm serves the aerospace and defense, automotive and trucking, aviation, chemicals, education, energy, financial institutions, and government contracting industries. The company was founded in 1979 and is headquartered in Washington, DC. | Corporate Officer/Principal | 2003-01-31 |
Serono SA
 Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Director/Board Member | 2000-02-29 |
The World Economic Forum USA, Inc.
 The World Economic Forum USA, Inc. Miscellaneous Commercial ServicesCommercial Services The World Economic Forum USA, Inc. operates an organization for economic reforms. The non-profit company is based in New York, NY. | Corporate Officer/Principal | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Chief Administrative Officer | - |
Training of Kathryn L. Biberstein
| Kettering University | Undergraduate Degree |
| The University of Michigan Law School | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Private companies | 6 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Crowell & Moring LLP
Crowell & Moring LLP Miscellaneous Commercial ServicesCommercial Services Crowell & Moring LLP provides legal services. It offers litigation and arbitration, regulatory, and transactional matters. The firm serves the aerospace and defense, automotive and trucking, aviation, chemicals, education, energy, financial institutions, and government contracting industries. The company was founded in 1979 and is headquartered in Washington, DC. | Commercial Services |
The World Economic Forum USA, Inc.
The World Economic Forum USA, Inc. Miscellaneous Commercial ServicesCommercial Services The World Economic Forum USA, Inc. operates an organization for economic reforms. The non-profit company is based in New York, NY. | Commercial Services |
Triplet Therapeutics, Inc.
Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Triplet Therapeutics, Inc. develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases. The company was founded by Jean-François Formela and Nessan Bermingham is headquartered in Cambridge, MA. | Health Services |
| Meridian Stories |
- Stock Market
- Insiders
- Kathryn L. Biberstein